Boehringer Ingelheim Ends Development of Obesity Drug in Gubra Partnership
In a recent announcement, Boehringer Ingelheim has decided to end the development of one of its obesity drug candidates from ...
In a recent announcement, Boehringer Ingelheim has decided to end the development of one of its obesity drug candidates from ...
© 2020 The Lagos Today - Nkali.